July 18, 2013
Gilead Sciences to Release Second Quarter 2013 Financial Results on Thursday, July 25, 2013
Conference Call and Webcast to Follow
FOSTER CITY, Calif.--(BUSINESS WIRE)--Jul. 18, 2013--
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second
quarter 2013 financial results will be released on Thursday, July 25, at
4:05 p.m. Eastern Time. At 4:30 p.m. Eastern Time, Gilead’s management
will host a conference call to discuss the company’s financial results
for the second quarter and provide a general business update. The
conference call will be accessible via the internet from the company’s
website.
To access the webcast link, log on to www.gilead.com.
Please connect to the company’s website at least 15 minutes prior to the
conference call to ensure adequate time for any software download that
may be required to listen to the webcast. Alternatively, please call
1-866-730-5771 (U.S.) or 1-857-350-1595 (international) and dial the
participant passcode 26371472 to access the call. Telephone replay will
be available approximately two hours after the call through 11:59 p.m.
Eastern Time, July 28, 2013. To access the replay, please call
1-888-286-8010 (U.S.) or 1-617-801-6888 (international) and dial the
participant passcode 87549354. The webcast will be archived on www.gilead.com
for one year.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases worldwide. Headquartered in Foster City,
California, Gilead has operations in North America, Europe and Asia
Pacific.
For more information on Gilead Sciences, please visit www.gilead.com
or call the Gilead Public Affairs Department at 1-800-GILEAD-5
(1-800-445-3235).
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Investor
Relations
